Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy
- PMID: 9548613
- DOI: 10.1080/00365529850170775
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy
Abstract
Background: The Maastricht Consensus Report advises that, in Helicobacter pylori-positive patients after surgery for peptic ulcer disease, H. pylori should be eradicated. The aim of the present study was to investigate the symptomatic response of H. pylori eradication in previously vagotomized peptic ulcer patients with persistent dyspeptic complaints.
Methods: The study was performed as a randomized, double-blind, placebo-controlled study. Pretreatment diagnostic upper endoscopy was omitted. All the results were submitted to intention-to-treat and efficacy analyses.
Results: We could not find any differences between the two groups with regard to intensity or frequency of upper abdominal pain, nausea, heartburn, or other abdominal symptoms during the 12-month follow-up. The triple therapy eradication rate was 88% at both 3- and 12-month controls.
Conclusion: Vagotomized peptic ulcer patients with persistent dyspeptic complaints should undergo a diagnostic upper endoscopy to detect ulcer recurrence before H. pylori eradication treatment is considered.
Similar articles
-
CagA status and Helicobacter pylori eradication among dyspeptic patients.Gastroenterol Hepatol. 2005 Oct;28(8):441-4. doi: 10.1157/13078993. Gastroenterol Hepatol. 2005. PMID: 16185577
-
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061. J Gastroenterol. 2003. PMID: 12743773 Clinical Trial.
-
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x. Am J Gastroenterol. 1998. PMID: 9576452 Clinical Trial.
-
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.Helicobacter. 1998 Sep;3(3):195-201. doi: 10.1046/j.1523-5378.1998.08029.x. Helicobacter. 1998. PMID: 9731991
-
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].Nihon Rinsho. 1999 Jan;57(1):127-33. Nihon Rinsho. 1999. PMID: 10036949 Review. Japanese.
Cited by
-
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis.Dig Dis Sci. 1999 Dec;44(12):2439-42. doi: 10.1023/a:1026674719476. Dig Dis Sci. 1999. PMID: 10630494 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical